Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Murtaza Adam (NPI 1093004806)

Field	Value
Entity Type	Individual
Organization	Murtaza Adam
Address	11960 Lioness Way Ste 290
City	Parker
State	CO
ZIP	80134
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 1, 2011

Payer Source	Total Paid
Medicare	$2.3M
Medicaid	$0

Key Findings

This provider is a retina-focused ophthalmologist with a long Medicare billing history, enumerated on 2011-04-01 (~15 years ago). The CPT/HCPCS mix is dominated by intravitreal injection and retina imaging services (notably J0178, J2777, 67028, 92134), indicating a clinical practice centered on medical retina care and frequent in-office injectable therapies rather than broad general ophthalmology or primary care visits.

Medicare revenue concentration is high: total Medicare revenue reported is $2.3M and the precomputed top 3 Medicare codes by revenue account for 75.7% of that total. The three highest-revenue codes are J0178 (48.3% of Medicare revenue), J2777 (21.7%), and 67028 (5.7%), so anti-VEGF/novel intravitreal biologic administrations and standalone intravitreal injection procedures drive the majority of payer dollars.

This provider effectively operates as single-payer for the dataset: there is no Medicaid billing on file. The absence of any Medicaid revenue means Medicare constitutes the entire reported public payer revenue base, which limits visibility into Medicaid patient volume and suggests payer mix is heavily Medicare-weighted or that Medicaid-insured patients are not a material group for this NPI.

On several high-revenue codes the provider’s national standing is around typical to above-typical volume: J0178 ranks #733 of 3204 providers (77th percentile) and J2777 ranks #617 of 2039 providers (70th percentile), both described as typical, unremarkable volumes. These percentiles indicate the provider is an active, consistent participant in intravitreal therapeutic delivery but not a dominant national outlier for those drug codes.

There are specific statistical outliers and specialty-service signals in the profile. 92134 (retinal computerized diagnostic imaging) is listed as an extreme outlier, at the 98th percentile nationally, indicating unusually high imaging volume relative to peers. Additionally, evaluation/management codes like 92014 and 99204 appear notably above typical national volume (92014 at the 95th percentile; 99204 at the 95th percentile), suggesting substantial office-based follow-up and new patient evaluation activity alongside procedural work.

The provider performs a mix of procedural retina surgeries at volumes above many peers: 67036 ranks in the 96th percentile (#35 of 832) and 67042 is in the 80th percentile, which together indicate a meaningful surgical retina component (pars plana vitrectomy and membrane peeling procedures) beyond injection-only practice. These surgical codes, while smaller contributors to total revenue, signal capability to manage more complex retinal disease and perform operative interventions.

Drug billing mix includes both branded biologics and biosimilars/compounded agents: high revenue from J0178 (aflibercept) and significant billing for J2777 (faricimab) plus J3490 and J7999 entries for unclassified or compounded drugs. This pattern is consistent with retina practices that administer a range of intravitreal therapeutics and occasionally bill non-standard or compounded agents.

Given the revenue and code mix, the practice model appears procedure- and infusion-centric: roughly three-quarters of Medicare dollars come from intravitreal drug administration and related injection procedures, while imaging (92134) and E/M services support pre- and post-procedure management. For payers and network planners, this profile aligns with a specialty retina clinic that provides frequent in-office biologic therapy, high-volume retina imaging, and a non-trivial surgical caseload.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,630	$690	$1.1M
J2777	Injection, faricimab‑svoa, 0.1 mg	17,460	$30	$506.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,360	$100	$132.2K
J3490	Unclassified drugs	50	$1,780	$90.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	940	$90	$88.1K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	710	$120	$84.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,510	$30	$77.8K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	70	$570	$39.5K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	40	$900	$31.6K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	130	$220	$28.8K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Murtaza Adam — 4 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	8	60	740	$690	$618.3K
J2777	13	40	8,910	$30	$456.1K
J2781	6	10	470	$120	$79.4K
Q5128	10	10	220	$220	$76.1K
67028	13	80	670	$100	$73.3K
67036	3	30	20	$1,100	$37.3K
67042	6	30	20	$1,140	$29.6K
67039	2	10	20	$1,230	$27.2K
J3490	31	60	50	$290	$23.1K
J7999	18	50	230	$70	$21.5K

Showing 1–10 of 24

Related Providers

Other providers that share a Tax Identification Number (TIN) with Murtaza Adam, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Alok Bansal	CA	Ophthalmology Physician	$3M	$4.7M
David Reed	MA	Retina Specialist (Ophthalmology) Physician	$7.7M	$0
Omesh Gupta	PA	Ophthalmology Physician	$7.1M	$80
Mitchell Fineman	PA	Ophthalmology Physician	$7M	$0
Richard Kaiser	PA	Ophthalmology Physician	$6.6M	$0
Carl Regillo	PA	Ophthalmology Physician	$6.5M	$0
Allen Ho	PA	Ophthalmology Physician	$6.4M	$0
James Vander	PA	Ophthalmology Physician	$6.3M	$0
Marc Spirn	PA	Ophthalmology Physician	$6.3M	$0
Arunan Sivalingam	PA	Ophthalmology Physician	$6M	$0

Nearby Providers

Other providers in the same ZIP code as Murtaza Adam, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Caregivers Village Colorado LLC	CO	In Home Supportive Care Agency	$0	$18.2M
Shahid Javery	CO	Internal Medicine Physician	$11.4M	$0
Prk Williams Inc.	CO	In Home Supportive Care Agency	$0	$8M
Metro Community Provider Network Inc	CO	Federally Qualified Health Center (FQHC)	$0	$3.8M
Cher, LLC	CO	Diagnostic Radiology Physician	$517.7K	$456.8K
Milestone Surgical Center LLC	CO	Ambulatory Surgical Clinic/Center	$431.4K	$0
Carl Tubbs	CO	Ophthalmology Physician	$378.5K	$0
Carl Johnson	CO	Ophthalmology Physician	$342.7K	$0
Vikas Reddy	CO	Family Medicine Physician	$328.7K	$0
Wendy Archuleta	CO	Family Nurse Practitioner	$289.7K	$0

Murtaza Adam — Billing Profile & Reimbursement Data

Sign up for Murtaza Adam — Billing Profile & Reimbursement Data policy alerts

Murtaza Adam — Billing Profile & Reimbursement Data

Sign up for Murtaza Adam — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References